15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $276M | $17M | 74.4% | 4.0% | $25M | — | $100M |
| 2024 | $237M | $10M | 72.6% | 1.9% | -$6M | — | $75M |
| 2023 | $198M | -$3M | 68.6% | -3.3% | $15M | — | $69M |
| 2022 | $164M | -$17M | 67.1% | -10.4% | $10M | — | $51M |
| 2021 | $153M | -$7M | 69.3% | -5.1% | $21M | — | $68M |
| 2020 | $122M | $3M | 69.1% | 1.9% | $15M | — | $34M |
| 2019 | $118M | -$10M | 68.1% | -9.5% | -$10M | — | $27M |
| 2018 | $91M | -$8M | 64.6% | -4.3% | -$3M | — | $18M |
| 2017 | $63M | -$17M | 53.5% | -23.9% | -$15M | $17M | $27M |
| 2016 | $54M | -$20M | 47.9% | -35.4% | -$21M | $9M | — |
| 2015 | — | -$16M | — | — | -$16M | $71000 | — |
| 2014 | — | -$20M | — | — | — | $109000 | — |
| 2014 | — | -$292M | — | — | — | — | — |
| 2013 | — | -$16M | — | — | — | — | $8M |
| 2013 | — | -$283M | — | — | — | — | $11M |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $68M | -$6M | 72.0% | -11.8% | $15M | — | $109M |
| Dec '25 | $93M | $23M | 78.7% | 24.1% | $13M | — | $100M |
| Sep '25 | $68M | $5M | 73.5% | 5.1% | $19M | — | $100M |
| Jun '25 | $63M | -$553000 | 73.7% | -3.2% | $81000 | — | $81M |
| Mar '25 | $53M | -$11M | 69.0% | -24.3% | -$8M | — | $73M |
| Dec '24 | $75M | $20M | 77.6% | 24.5% | $8M | — | $75M |
| Sep '24 | $58M | -$901000 | 71.9% | -4.3% | -$9M | — | $54M |
| Jun '24 | $53M | -$5M | 69.5% | -11.5% | $2M | — | $50M |
| Mar '24 | $51M | -$4M | 68.9% | -10.7% | -$7M | — | $63M |
| Dec '23 | $65M | $13M | 74.6% | 19.6% | $2M | — | $69M |
| Sep '23 | $46M | -$4M | 67.2% | -11.1% | $600000 | — | $60M |
| Jun '23 | $46M | -$5M | 65.2% | -13.0% | $6M | — | $43M |
| Mar '23 | $41M | -$7M | 64.7% | -19.9% | $6M | — | $62M |
| Dec '22 | $53M | $6M | 72.6% | 11.5% | $6M | — | $51M |
| Sep '22 | $38M | -$7M | 65.8% | -17.7% | $3M | — | $65M |
| Jun '22 | $37M | -$9M | 62.1% | -24.7% | $1M | — | $56M |
| Mar '22 | $36M | -$7M | 65.4% | -20.3% | $387000 | — | $56M |
| Dec '21 | $47M | $5M | 72.3% | 8.8% | $10M | — | $68M |
| Sep '21 | $34M | -$5M | 65.5% | -14.7% | $1M | — | $55M |
| Jun '21 | $39M | -$4M | 69.6% | -9.6% | $3M | — | $52M |
How the market has priced VCEL against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, Vericel Corp's revenue has grown 17.8% per year, and net income grown 42.0% per year. These are computed facts, not advice.
As of FY2025, Vericel Corp reported — of total debt against $100M of cash; operating income covered interest expense 18×.
In FY2025, gross margin was 74.4%, operating margin 4.0%, and net margin 6.0%.
As of Jun '26, Vericel Corp traded at a price-to-earnings ratio of about 132.4× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S have moved with the share price. These are computed facts, not advice.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.